2025 Partners
Alamar Biosciences
Lead Partner
Alamar Biosciences is powering precision proteomics with automated, high-throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels in liquid biopsy samples. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture-and-release method, reducing background signal and increasing sensitivity and dynamic range compared with standard approaches. The NULISA Platform allows for a fully automated workflow with the ARGO™ System, enabling less than 30 minutes hands-on time from sample to data.
Atuka
Expertise Partner
Atuka provides contract research and consultancy services for the biopharmaceutical industry with world-leading expertise in Parkinson’s disease and related neurological conditions. We provide cutting-edge, rodent and non-human primate models (toxin and molecular pathology-driven) to evaluate efficacy and target engagement over a comprehensive range of symptomatic, motor (e.g. parkinsonism and dyskinesia), non-motor (e.g. cognition and impulse control) and disease-modification assays. Atuka also offers biodistribution (e.g. AAVs, ASOs) and non-GLP safety assessments in non-human primates, DMPK and in-vivo imaging services to aid development of novel therapeutics.
Lumanity
Hosting Partner
Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Contact us to learn more about how Lumanity can support your unique challenge.
Transpharmation
Program Partner
Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience expertise, utilizing behavioral and molecular assays to help clients benchmark compounds. With extensive experience in antibiotic treatments and diet manipulations, we study their effects on the microbiome. Committed to on-time data delivery and providing flexible, customized solutions, we support clients in optimizing preclinical assets for the development of life-changing medicines.
CND Life Sciences
Program Partner
CND Life Sciences is a medical technology company offering cutaneous testing and biomarker services for neurodegenerative disorders. The Syn-One Test® detects, visualizes, and quantifies misfolded alpha-synuclein in cutaneous nerves with greater than 95% sensitivity and specificity to aid in the diagnosis of Parkinson’s disease and related disorders. The test utilizes a simple in-office skin biopsy procedure to provide clinicians and patients with unique pathological insights as early in the disease process as possible. CND collaborates with biopharmaceutical companies to help optimize clinical trials for investigational drugs by quantifying alpha-synuclein in cutaneous nerves and measuring its volume over time with assistance from the company’s NerValence AI-based system.
Creative Biolabs
Innovation Partner
Creative Biolabs is a global CRO leader in antibody therapeutics and neuroscience research. We provide integrated discovery-to-preclinical solutions through cutting-edge platforms for antibody drug development (monoclonal, bispecific, ADC), CAR-T, and gene therapy R&D. As pioneers in neuroscience, we provide high-quality antibodies, proteins, cell tools, and tailored services to streamline neurological studies. Leveraging integrated global networks and evolving technologies, we empower worldwide clients to enhance project success rates and drive transformative life science innovations.
Unlearn. AI
Innovation Partner
At Unlearn, we believe that AI will not just revolutionize medicine—it will redefine it, transforming the lives of millions. Our mission is clear: to advance AI to eliminate trial and error in medicine.
Today, we’re pioneering digital twins of patients that solve key pain points across clinical development, delivered through the Unlearn Platform. And this is just the beginning. In the future, our technology will transform medicine into a computational science. As we continuously improve our AI, we aim to shape a future where precision medicine becomes the norm, setting a new standard of care that enables better health outcomes for all.
Ariadne. Ai
Innovation Partner
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
BrainXell
Exhibition Partner
BrainXell provides high-purity, iPSC-derived human neurons and glia for research and development with a focus on drug discovery. Utilizing proprietary technology, we generate high purity, subtype-specific neurons that mature rapidly and are quickly andeasily ready for a variety of assays. Multiple neuron subtypes relevant to a range of disorders are available. Additionally, each neuron subtype can be made in custom batches from 50 million to 10 billion neurons from unique iPSC lines. We are dedicated to delivering the highest quality products for off-the-shelf neurons and custom service projects.
Quanterix
Exhibition Partner
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through the Company’s unparalleled sensitivity and flexibility. Its industry-leading Simoa® precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding, management and patient care in neurology, oncology, immunology, cardiology and infectious disease for nearly two decades.
BioIVT
Exhibition Partner
BioIVT's Center for NeuroExcellence is the largest private global source of longitudinally collected human cerebrospinal fluid (CSF) from control as well as diseased populations. Samples are available immediately and are collected under US IRB-approved protocols. Our biorepository consists of CSF, CSF cell pellet collections, as well as additional banked biomaterial matched to CSF including PAXGene RNA, serum, plasma, blood cell pellet, and urine. All are prospectively consented and include detailed longitudinal clinical data.
C₂N
Event Partner
C₂N Diagnostics provide exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health. Our high-resolution mass spectrometry-based biomarker services and products are used for: clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiologic studies to improve global public health. C₂N assays have been used in over 150 Alzheimer’s disease and other research studies throughout the U.S. and the world.
Please visit: www.C2N.com
Catalent Pharma Solutions
Event Partner
With more than 35 products launched in over 60 countries, the Zydis® ODT (orally disintegrating tablet) fast-dissolve technology continues to be the world’s best-in-class ODT technology. The Zydis fast-dissolve platform consists of three technologies: Zydis ODT, Zydis Ultra, and Zydis Bio. Zydis ODT is a unique freeze-dried dosage form that disperses within three seconds without the need for water. Zydis Ultra technology offers enhanced taste-masking capabilities, increased drug loading, and the potential for functional coating. Zydis Bio technology offers a formulation strategy for oral delivery of peptides, allergens, and viral vaccines.
FUJIFILM
Event Partner
FUJIFILM Cellular Dynamics, Inc. (FCDI) is a leading developer and supplier of human induced pluripotent stem cells (iPSCs) utilized in drug discovery and cell therapies. The company uses its expertise in iPSC technologies to develop a robust pipeline of life science research tools, including iCell® products. These cells are highly pure, highly reproducible, and available in industrial quantities in many cell types and sourced from multiple cell lines which can be applied for drug discovery, target identification and toxicity testing.
Please visit: www.fujifilmcdi.com
Sebia
Event Partner
Our mission is to provide powerful tools that translate what is happening in a patient’s body into a readable and interpretable language.
We call it our new language of life.
The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE), Mass Spectrometry, and creative Gel Electrophoresis techniques produce accurate and efficient methods of separation to unlock these complex conditions.
Sebia is a global specialized In Vitro Diagnostic player providing equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmune & Infectious diseases and other rare pathologies.
Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.
Please visit: www.sebia.com
Stellaromics
Event Partner
Stellaromics is a privately held company dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health. Stellaromics is headquartered in Boston, Massachusetts, USA.